Evidence map›Paper›PMID 27377170›Full record

ArticleJournal of the American Geriatrics Society2016

Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity.

Khadija Ismail, Lisa Nussbaum, Paola Sebastiani, Stacy Andersen, Thomas Perls, Nir Barzilai, Sofiya Milman

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 2 pooled it
35.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 2 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. APOE Alleles and Extreme Human Longevity.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Pooled it
  2. Limitations and risks of meta-analyses of longevity studies.Mechanisms of ageing and development · 2017
    Pooled it
  3. Article
  4. Article
  5. Repurposing niclosamide to mitigate inflammaging: a review of multi-target mechanisms in cellular senescence and age-related decline.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  6. Observational
  7. Machine learning prediction of survival in centenarians after age 100: a retrospective, population-based cohort study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mortality Trends in Pre-COVID-19 and COVID-19 Eras Among Oldest Veterans.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Workshop Report-Heterogeneity and Successful Aging Part I: Heterogeneity in Aging-Challenges and Opportunities.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  19. Tailored Approach to Designing a Digital Research Platform for Adults Aged 95 and Older: SuperAgers Family Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Khadija IsmailDivision of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.
Lisa NussbaumDepartment of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts.
Paola SebastianiDepartment of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts.
Stacy AndersenGeriatrics Section, Department of Medicine, School of Medicine, Boston University and Boston Medical Center, Boston, Massachusetts.
Thomas PerlsGeriatrics Section, Department of Medicine, School of Medicine, Boston University and Boston Medical Center, Boston, Massachusetts.
Nir BarzilaiDivision of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.
Sofiya MilmanDivision of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.
Albert Einstein College of Medicine · USBoston University · USBoston Medical Center · US

Funding

Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI Thomas Girke, NICHOLAS Joseph SCHORK · 2004 to 2026
$102.6M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
The Long Life Family StudyU01AG023755 · NIA · BOSTON MEDICAL CENTER · PI PERLS, THOMAS T · 2004 to 2018
$13.2M
ROLE OF NUTRIENTS IN AGE-RELATED INSULIN RESISTANCEP01AG021654 · NIA · YESHIVA UNIVERSITY · PI SHAMOON, HARRY · 2003 to 2007
$10.6M
LGP/LongenityR01AG046949 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BARZILAI, NIR J · 2013 to 2017
$2.4M
Epigenetic Profiling in Healthy Aging and Exceptional LongevityR01AG042188 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ATZMON, GIL, BARZILAI, NIR J · 2011 to 2015
$2.0M
Clinical and Translational Science AwardKL2TR001071 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHAMOON, HARRY · 2013 to 2017
$968k
Clinical and Translational Science AwardTL1TR001072 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHAMOON, HARRY · 2013 to 2017
$909k
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survivalK23AG051148 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MILMAN, SOFIYA · 2015 to 2018
$791k
NCATS NIH HHS KL2 TR001071NCATS NIH HHS TL1 TR001072NCATS NIH HHS UL1 TR001073NIA NIH HHS K23 AG051148NIA NIH HHS P01 AG021654NIA NIH HHS R01 AG042188NIA NIH HHS R01 AG046949NIA NIH HHS U01 AG023755NIA NIH HHS U19 AG023122NIDDK NIH HHS P30 DK020541
6 · The paper itself

Abstract

objectivesTo determine, in a sample of Ashkenazi Jewish aged 95 and older, whether there is a compression of morbidity similar to what has been reported in other cohorts with exceptional longevity.

designCase-control study.

settingLongevity Genes Project (LGP) and New England Centenarian Study (NECS).

participantsLGP (n = 439, mean age 97.8 ± 2.8) and NECS (n = 1,498, mean age 101.4 ± 4.0) participants with exceptional longevity and their respective younger referent cohorts (LGP, n = 696; NECS, n = 302). MEASUREMENTS: Self- and proxy reports of age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, osteoporosis, and stroke.

resultsLong-lived individuals from LGP and NECS had later age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, and osteoporosis than their respective younger reference groups. The risk of overall morbidity was lower in participants with exceptional longevity than in younger participants (NECS men: relative risk (RR) = 0.12, women: RR = 0.20; LGP men: RR = 0.18, women: RR = 0.24). The age at which 20% of each of the groups with exceptional longevity experienced specific diseases was between 18 and 24 years later than in the reference groups, stratified according to sex.

conclusionThe similar extension of health span and compression of morbidity seen in NECS and LGP participants with exceptional longevity further validates the utility of these rare individuals for the study of factors that delay or prevent a broad spectrum of diseases otherwise associated with mortality and disability.

Indexed as

LongevityAged, 80 and overAge of OnsetCase-Control StudiesChronic DiseaseCohort StudiesFemaleHumansJewsMaleReference ValuesRiskUnited Statescompression of morbidityhealth spanlongevityolder adults

Identifiers

PMID27377170
PMCPMC4988893
OpenAlexW2468091767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.